Apogee (APOG) Stock Trades Down, Here Is Why

StockStory
08 Jan

What Happened?

Shares of architectural products company Apogee (APGE) fell 17% in the morning session after the company reported underwhelming calendar fourth-quarter 2024 results. Sales were flat year on year, and this weighed on profits as operating margin fell. In addition, its full-year EPS guidance slightly missed, suggesting the weakness might be more pronounced in the coming quarters. Overall, we think this was a challenging quarter. 

What The Market Is Telling Us

Apogee’s shares are not very volatile and have only had 8 moves greater than 5% over the last year. Moves this big are rare for Apogee and indicate this news significantly impacted the market’s perception of the business. 

Apogee is down 16.9% since the beginning of the year, and at $59.22 per share, it is trading 32.1% below its 52-week high of $87.22 from November 2024. Investors who bought $1,000 worth of Apogee’s shares 5 years ago would now be looking at an investment worth $1,814. 

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10